Sandbox Reserved 314

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 20: Line 20:
Geneticin is more toxic to eukaroytic organisms than paromomycin, especially in the absence of an inactivating enzyme or targeted drug.2
Geneticin is more toxic to eukaroytic organisms than paromomycin, especially in the absence of an inactivating enzyme or targeted drug.2
<Structure load='1mwl' size='250' frame='true' align='right' caption='Trial2' scene='Insert optional scene name here' />
<Structure load='1mwl' size='250' frame='true' align='right' caption='Trial2' scene='Insert optional scene name here' />
 +
Geneticin has been used in a study for current drug therapy that targets ornithine decarboxylase for treatment of African sleeping sickness. Geneticin was discovered to be a weak non-competitive inhibitor of orthnithine decarboxylase found in Trypanosoma brucei, however, the structural analysis of bound ornithine decarboxylase to geneticin has provided a basis into the enzyme's function. <ref name="jackson">PMID: 12672797</ref>

Revision as of 16:27, 29 March 2011

This Sandbox is Reserved from January 10, 2010, through April 10, 2011 for use in BCMB 307-Proteins course taught by Andrea Gorrell at the University of Northern British Columbia, Prince George, BC, Canada.
To get started:
  • Click the edit this page tab at the top. Save the page after each step, then edit it again.
  • Click the 3D button (when editing, above the wikitext box) to insert Jmol.
  • show the Scene authoring tools, create a molecular scene, and save it. Copy the green link into the page.
  • Add a description of your scene. Use the buttons above the wikitext box for bold, italics, links, headlines, etc.

More help: Help:Editing


Geneticin

Contents

Geneticin, also known as gentamicin or G418, belongs to a group of positively charged sugar derivatives known as aminoglycosides. Aminoglycosides contain three rings that possess hydroxyl, ammonium, and methyl groups.[1] This group of proteins bind to different regions of the 30S particle of the ribosome interfering with protein synthesis. The different regions of the ribosome they bind to depend on their chemical structures. Because geneticin is capable of binding to the 80S ribosome, it is known to be toxic to eukaryotic organisms. However, studies have shown that geneticin can be used in medicine to treat parasites and in the treatment of genetic disorders.

Geneticin

Drag the structure with the mouse to rotate

Structure

Aminoglycosides all contain a central 2-deoxystreptamine, or 2-DOS or Ring II, containing an ammonium group on either side of the deoxy carbon and attached to Ring I at position 4. This structure forms the neamine moiety.[2] The neamine moiety forms base pairs with C1407-G1494 and the non-Watson-Crick pair U1406-U1495, of the decoding site RNA. Since these base pairs are conserved in both the prokaryotes and eukaryotes, molecular discrimination of the bacterial target is provided by the sugar substituents occuring at positions 4-, 5-, and 6- of the neamine moiety.[3]

Geneticin contains three rings which are functionalized by hydroxyl, ammonium and methyl groups. When geneticin is bound to the eubacterial decoding A site, the complex is comprised of a double helix with 16 Watson-Crick pairs, two UU pairs, and two unpaired and four adenine bases.[1] The neamine moiety, influences the adenine bases 1492 and 1943 of each site to turn away from the helix forming base triples with G-C pairs. In site I and II, 14 hydrogen bonds occur between geneticin and the base atoms and phosphate oxygen atoms of the A site. [1] Flipped out adenine bases 1492 and 1493 allow Ring I to intercalate inside the helix and is stabilized by stacking against G1491. The phosphate groups of the bulged adenine bases are hydrogen bonded to two hydroxyl groups. Intramolecular hydrogen bonds occur between Ring II and the other two rings and ammonium N3 is completely dehydrated. [1]

Function

Geneticin, and other aminoglycosides, inhibit bacterial protein synthesis and are commonly used to treat infections induced by Gram-negative bacteria, such as Escherichia coli. [4] They prevent the ability of tRNA to bind to the A site of the bacterial 16S rRNA ribosome by binding to the A site. Aminoglycosides are toxic to mammalian systems, primarily through kidney and ear-associated illnesses.[1] Geneticin is more toxic to eukaroytic organisms than paromomycin, especially in the absence of an inactivating enzyme or targeted drug.2

Trial2

Drag the structure with the mouse to rotate

Geneticin has been used in a study for current drug therapy that targets ornithine decarboxylase for treatment of African sleeping sickness. Geneticin was discovered to be a weak non-competitive inhibitor of orthnithine decarboxylase found in Trypanosoma brucei, however, the structural analysis of bound ornithine decarboxylase to geneticin has provided a basis into the enzyme's function. [5]


References

  1. 1.0 1.1 1.2 1.3 1.4 Vicens Q, Westhof E. Crystal structure of geneticin bound to a bacterial 16S ribosomal RNA A site oligonucleotide. J Mol Biol. 2003 Feb 28;326(4):1175-88. PMID:12589761
  2. Francois B, Russell RJ, Murray JB, Aboul-ela F, Masquida B, Vicens Q, Westhof E. Crystal structures of complexes between aminoglycosides and decoding A site oligonucleotides: role of the number of rings and positive charges in the specific binding leading to miscoding. Nucleic Acids Res. 2005 Oct 7;33(17):5677-90. Print 2005. PMID:16214802 doi:33/17/5677
  3. Han Q, Zhao Q, Fish S, Simonsen KB, Vourloumis D, Froelich JM, Wall D, Hermann T. Molecular recognition by glycoside pseudo base pairs and triples in an apramycin-RNA complex. Angew Chem Int Ed Engl. 2005 Apr 29;44(18):2694-700. PMID:15849690 doi:10.1002/anie.200500028
  4. Morris JC, Ping-Sheng L, Zhai HX, Shen TY, Mensa-Wilmot K. Phosphatidylinositol phospholipase C is activated allosterically by the aminoglycoside G418. 2-deoxy-2-fluoro-scyllo-inositol-1-O-dodecylphosphonate and its analogs inhibit glycosylphosphatidylinositol phospholipase C. J Biol Chem. 1996 Jun 28;271(26):15468-77. PMID:8663028
  5. Jackson LK, Goldsmith EJ, Phillips MA. X-ray structure determination of Trypanosoma brucei ornithine decarboxylase bound to D-ornithine and to G418: insights into substrate binding and ODC conformational flexibility. J Biol Chem. 2003 Jun 13;278(24):22037-43. Epub 2003 Apr 2. PMID:12672797 doi:10.1074/jbc.M300188200

2 Griffiths, J.K., Balakrishnan, R., Widmer, G., and Tzipori, S. 1998. Paromomycin and Geneticin inhibit intracellular Cryotosporidium parvum without trafficking through the host cell cytoplasm: implications for drug delivery. Infection and Immunity. 66:3874-3883.

Personal tools